Lifting lockdown COVID19 restrictions: What can pharmacists do as the world wakes up?

Ashkanani, Fatemah; Richardson, R. H.; Lindsey, Laura; Rathbone, Adam Pattison

doi:10.1016/j.rcsop.2021.100028

Cited by 2 publications

(2 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…On the other hand, poor sleep quality creates a feeling of frustration and isolation. Individuals' contacts with others may be disrupted due to an irregular sleep-wake schedule ( Altena et al, 2020 , Ashkanani et al, 2021 ; Leen et al; Potter et al, 2016 ). As a result, limiting tension and probably preventing social relationship disturbances during home confinement can be accomplished by managing sleep issues as best as possible.…”

Section: Covid-19 and Nervous Systemmentioning

confidence: 99%

The potential impact of Covid-19 on CNS and psychiatric sequels

Dehghani

Zokaei

Kahani

et al. 2022

Asian Journal of Psychiatry

View full text Add to dashboard Cite

Section: Covid-19 and Nervous Systemmentioning

confidence: 99%

The potential impact of Covid-19 on CNS and psychiatric sequels

Dehghani

Zokaei

Kahani

et al. 2022

Asian Journal of Psychiatry

View full text Add to dashboard Cite

“…To address the potential risks of prolonged NSAIDs use, deprescribing programs have emerged as a viable strategy to minimize harm in patients requiring pain management [15][16][17]. Pharmacist-led deprescribing programs have gained recognition for their role in optimizing medication use and reducing the risks associated with long-term drug therapy [18][19][20]. Such programs aim to assess the necessity and appropriateness of ongoing drug therapy, gradually taper drug doses, explore alternative treatment options, and ultimately discontinue medications when the potential harms outweigh the benefts [21,22].…”

Section: Introductionmentioning

confidence: 99%

Efficacy and Safety of Pharmacist-Managed NSAIDs Deprescribing: A Jordanian Outpatient Study

Jaber,

Al Shihab,

Tamimi

2024

Journal of Clinical Pharmacy and Therapeutics

View full text Add to dashboard Cite

Background. Nonsteroidal anti-inflammatory drugs (NSAIDs) are commonly used to manage pain, including chronic pain conditions. However, their prolonged use is associated with significant risks, particularly gastrointestinal (GI) adverse events. This study aimed to evaluate the effectiveness and safety of a pharmacist-managed deprescribing program for NSAIDs in a Jordanian outpatient population. Methods. A convenience sample of 100 participants who had been using NSAIDs for pain management was recruited. Participants underwent a structured deprescribing intervention in collaboration with physicians. Various effectiveness and safety outcomes were assessed before and after deprescribing. Descriptive statistics and chi-square test were used for data analysis. Results. The majority of participants reported chronic pain conditions, with rheumatoid arthritis (24%) and osteoarthritis (22%) being the most prevalent. Ibuprofen (28%) and diclofenac (22%) were the most commonly used NSAIDs. The deprescribing program was associated with a significant reduction in heartburn, stomach ulcer, kidney problems and fluctuation in blood pressure readings (p<0.05), and pain exacerbation. Notably, the reduction in pain exacerbation was evident (p=0.003) in the 4-month follow-up. Conclusion. A pharmacist-managed NSAIDs deprescribing program demonstrated effectiveness in reducing the risk of GI adverse events and fluctuation in blood pressure readings without causing harm during a short-term follow-up. These findings support the feasibility of implementing such programs in outpatient settings. Further long-term investigations are necessary to confirm these results.

show abstract

Lifting lockdown COVID19 restrictions: What can pharmacists do as the world wakes up?

Cited by 2 publications

References 19 publications

The potential impact of Covid-19 on CNS and psychiatric sequels

The potential impact of Covid-19 on CNS and psychiatric sequels

Efficacy and Safety of Pharmacist-Managed NSAIDs Deprescribing: A Jordanian Outpatient Study

Contact Info

Product

Resources

About